Isabelle G. Solman

Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia

Isabelle G. Solman, Lisa K. Blum, Hana Y. Hoh et al. · Leukemia Research · 2020 · 73 citations · Full text

Life Sciences, Hematology, Immunology +17

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia

Thomas J. Kipps, Graeme Fraser, Steven Coutré et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 45 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia

Isabelle G. Solman, Lisa K. Blum, Jan A. Burger et al. · Leukemia Research · 2021 · 45 citations · Full text

Life Sciences, Hematology, Immunology +17

Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jacqueline C. Barrientos, Susan O’Brien, Jennifer R. Brown et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study

Carol Moreno, Isabelle G. Solman, Constantine S. Tam et al. · Blood Advances · 2023 · 17 citations · Full text

Life Sciences, Hematology, Immunology +17